Financials
Value Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 41.27 K285.2 K117.06 K — Research & development ——— — Operating income -41.27 K-285.2 K-117.06 K — Non-Operating Income, Total —1.68 M1.68 M — Interest expense, net of interest capitalized ——— — Non-Operating Income, excl. Interest Expenses —1.68 M1.68 M — Unusual income/expense ——— — Pretax income -41.27 K1.4 M1.56 M — Equity in earnings ——— — Taxes ——— — Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations -41.27 K1.4 M1.56 M — Discontinued operations ——— — Net income -41.27 K1.4 M1.56 M — Dilution adjustment —1.68 M— — Preferred dividends —1.68 M— — Diluted net income available to common stockholders -41.27 K1.4 M1.56 M — Basic earnings per share (Basic EPS) -0.010.070.09 — Diluted earnings per share (Diluted EPS) -0.010.070.09 — Average basic shares outstanding 3.75 M5.64 M8.58 M — Diluted shares outstanding 3.75 M5.64 M8.58 M — EBITDA ——— — EBIT ——— — Cost of revenue ——— — Other cost of goods sold ——— — Depreciation & amortization (cash flow) ——— —